Study of Radiolabeled Revumenib in Adults With Acute Leukemia
Clinical trial NCT05406817 · COMPLETED
Trial details
- NCT number
- NCT05406817
- Sponsor
- Syndax Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-05
- Primary completion
- 2024-11-18
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.